Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: A pilot study

Schizophrenia Research

Volumn 149, Issue 1-3, 2013, Pages 112-115

  Abdel Baki, Amal ^a,b   Brazzini Poisson, Véronique ^a,b   Marois, Francis ^d   Letendre, Élaine ^c   Karelis, Antony D ^d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Aerobic interval training; Antipsychotic complications; First episode psychosis; Non pharmacological treatment; Schizophrenia; Waist circumference

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CLOZAPINE; DESVENLAFAXINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; OXYGEN; QUETIAPINE; RISPERIDONE; VALPROIC ACID; VENLAFAXINE;

ADULT; AEROBIC EXERCISE; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; EXERCISE; FITNESS; HUMAN; MALE; METABOLIC DISORDER; OXYGEN CONSUMPTION; PILOT STUDY; PRIORITY JOURNAL; PSYCHOSIS; RESTING HEART RATE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREADMILL EXERCISE; WAIST CIRCUMFERENCE; WALKING; WEIGHT REDUCTION;

AEROBIC INTERVAL TRAINING; ANTIPSYCHOTIC COMPLICATIONS; FIRST-EPISODE PSYCHOSIS; NON-PHARMACOLOGICAL TREATMENT; SCHIZOPHRENIA; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; EXERCISE; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; METABOLIC DISEASES; OXYGEN CONSUMPTION; PHYSICAL FITNESS; PILOT PROJECTS; PSYCHOTIC DISORDERS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84881244569     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.06.040     Document Type: Article

References (23)

1. Alvarez-Jimenez M., Gonzalez-Blanch C., Vazquez-Barquero J.L., Perez-Iglesias R., Martinez-Garcia O., Perez-Pardal T., Ramirez-Bonilla M.L., Crespo-Facorro B. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J. Clin. Psychiatry 2006, 67(8):1253-1260.
2. Alvarez-Jimenez M., Gonzalez-Blanch C., Crespo-Facorro B., Hetrick S., Rodriguez-Sanchez J.M., Perez-Iglesias R., Vazquez-Barquero J.L. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs 2008, 22(7):547-562.
3. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br. J. Psychiatry 1997, 171:502-508.
4. Brown S., Kim M., Mitchell C., Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br. J. Psychiatry 2010, 196(2):116-121.
5. Chrysant S.G., Chrysant G.S. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J. Am. Soc. Hypertens. 2013, 7(1):85-94.
6. De Hert M., Correll C.U., Bobes J., Cetkovich-Bakmas M., Cohen D., Asai I., Detraux J., Gautam S., Moller H.J., Ndetei D.M., Newcomer J.W., Uwakwe R., Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011, 10(1):52-77.
7. Earnest C.P., Lupo M., Thibodaux J., Hollier C., Butitta B., Lejeune E., Johannsen N.M., Gibala M.J., Church T.S. Interval training in men at risk for insulin resistance. Int. J. Sports Med. 2013, 34(4):355-363.
8. Ebbeling C.B., Ward A., Puleo E.M., Widrick J., Rippe J.M. Development of a single-stage submaximal treadmill walking test. Med. Sci. Sports Exerc. 1991, 23(8):966-973.
9. Heggelund J., Nilsberg G.E., Hoff J., Morken G., Helgerud J. Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial. Nord. J. Psychiatry 2011, 65(4):269-275.
10. Hwang C.L., Wu Y.T., Chou C.H. Effect of aerobic interval training on exercise capacity and metabolic risk factors in people with cardiometabolic disorders: a meta-analysis. J. Cardiopulm. Rehabil. Prev. 2011, 31(6):378-385.
11. Kessler H.S., Sisson S.B., Short K.R. The potential for high-intensity interval training to reduce cardiometabolic disease risk. Sports Med. 2012, 42(6):489-509.
12. Kodama S., Saito K., Tanaka S., Maki M., Yachi Y., Asumi M., Sugawara A., Totsuka K., Shimano H., Ohashi Y., Yamada N., Sone H. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009, 301(19):2024-2035.
13. Kwon J.S., Choi J.S., Bahk W.M., Yoon Kim C., Hyung Kim C., Chul Shin Y., Park B.J., Geun Oh C. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial. J. Clin. Psychiatry 2006, 67(4):547-553.
14. Leucht S., Burkard T., Henderson J., Maj M., Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr. Scand. 2007, 116(5):317-333.
15. Littrell K.H., Hilligoss N.M., Kirshner C.D., Petty R.G., Johnson C.G. The effects of an educational intervention on antipsychotic-induced weight gain. J. Nurs. Scholarsh. 2003, 35(3):237-241.
16. Marzolini S., Jensen B., Melville P. Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: a multidisciplinary approach. Ment. Health Phys. Act. 2009, 2(1):29-36.
17. Mitchell A.J., Vancampfort D., Sweers K., van Winkel R., Yu W., De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders - a systematic review and meta-analysis. Schizophr. Bull. 2013, 39(2):306-318.
18. Poulin M.J., Chaput J.P., Simard V., Vincent P., Bernier J., Gauthier Y., Lanctot G., Saindon J., Vincent A., Gagnon S., Tremblay A. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust. N. Z. J. Psychiatry 2007, 41(12):980-989.
19. Sabaté, E., 2003. Adherence to long-term therapies - Evidence for action, World Health Organisation ed, Geneva, Switzerland, p. 211p.
20. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64(10):1123-1131.
21. Tjonna A.E., Lee S.J., Rognmo O., Stolen T.O., Bye A., Haram P.M., Loennechen J.P., Al-Share Q.Y., Skogvoll E., Slordahl S.A., Kemi O.J., Najjar S.M., Wisloff U. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008, 118(4):346-354.
22. Tjonna A.E., Stolen T.O., Bye A., Volden M., Slordahl S.A., Odegard R., Skogvoll E., Wisloff U. Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin. Sci. 2009, 116(4):317-326.
23. Zipursky R.B., Gu H., Green A.I., Perkins D.O., Tohen M.F., McEvoy J.P., Strakowski S.M., Sharma T., Kahn R.S., Gur R.E., Tollefson G.D., Lieberman J.A. Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br. J. Psychiatry 2005, 187:537-543.